ATARA BIOTHERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$8.01
-6.10%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-5.3%
3 months
-6.3%
6 months
+63.5%
1 year
-43.0%
Year to date
-55.7%
52-week range
$4.18 – $18.09
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$80.4M
P/E
-4.8
P/B
-2.2
P/S
13
Revenue
$6.19M
Net income
-$16.69M
Diluted EPS
-1.29
Gross margin
91.40%
Net margin
-269.40%
Return on equity
44.70%
Total debt
$50.32M
Cash
$3.22M
Free cash flow
-$21.3M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $630K | -$4.83M | 69.70% | -767.30% | -$3.34M |
| Mar 31, 2026 | $516K | -$4.15M | 76.00% | -803.30% | -$3.07M |
| Dec 31, 2025 | $1.6M | -$3.41M | 93.50% | -213.50% | -$5.14M |
| Sep 30, 2025 | $3.45M | -$4.3M | 96.70% | -124.60% | -$9.74M |
| Jun 30, 2025 | $17.58M | $2.39M | 96.80% | 13.60% | -$6.97M |
| Mar 31, 2025 | $98.15M | $38.01M | 79.20% | 38.70% | -$28.14M |
| Dec 31, 2024 | $32.75M | -$12.69M | 79.30% | -38.80% | -$24.56M |
| Sep 30, 2024 | $40.19M | -$21.91M | 81.10% | -54.50% | -$3.99M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ATRA news
All market newsNo ticker-linked stories are in the current archive.